We were delighted to be asked to work with Carrick Therapeutics, a company making new discoveries in targeting aggressive cancers. Bottletop has worked with CEO Dr. Elaine Sullivan and some of her team previously at AstraZeneca and at Lilly so we have a good understanding of the way scientists work and the need for accuracy and the importance of non-disclosure.
